MAP kinase–activated protein kinase 2 (MAPKAPK2; MK2); tumor necrosis factor-α (TNF-α) BriefCommunication Pages: 760 - 760
A detector to quantify antibody- and magnetic nanoparticle–tagged circulating tumor cells (CTCs) in whole blood BriefCommunication Pages: 766 - 766
Targeted mass spectrometry via selected reaction monitoring (SRM) assays for biomarker validation BriefCommunication Pages: 767 - 767
Mouse model for autism spectrum disorder (ASD) caused by mutations in SH3 and multiple ankyrin repeat domains 2 ( SHANK2 ) BriefCommunication Pages: 769 - 769
Ultrasound-stimulated microbubbles for disruption of tumor vasculature BriefCommunication Pages: 772 - 772
Topical delivery of small interfering RNA with spherical nucleic acid–nanoparticle conjugates BriefCommunication Pages: 773 - 773